Please Wait
Applying Filters...
menu
    • menu
    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Volanesorsen Sodium

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1TEGSEDI and WAYLIVRA revenue, net

    02 2Tegsedi and Waylivra Revenue, Net

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : TEGSEDI and WAYLIVRA revenue, net

    Volanesorsen

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Brand Name : TEGSEDI and WAYLIVRA revenue, net

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Ionis Pharmaceuticals

    Volanesorsen

    Main Therapeutic Indication : Genetic Disorders

    Currency : USD

    2021 Revenue in Millions : 56

    2020 Revenue in Millions : 70

    Growth (%) : -21

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Tegsedi and Waylivra Revenue, Net

    Volanesorsen

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Brand Name : Tegsedi and Waylivra Revenue, Net

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Ionis Pharmaceuticals

    Volanesorsen

    Main Therapeutic Indication : Genetic Diseases

    Currency : USD

    2022 Revenue in Millions : 30

    2021 Revenue in Millions : 56

    Growth (%) : -46

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Tegsedi and Waylivra Revenue, Net

    Volanesorsen

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Brand Name : Tegsedi and Waylivra Revenue, Net

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Ionis Pharmaceuticals

    Volanesorsen

    Main Therapeutic Indication : Genetic Diseases

    Currency : USD

    2023 Revenue in Millions : 35

    2022 Revenue in Millions : 30

    Growth (%) : 16

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF